Should you buy CPRX stock?
Last updated:
Based on market data through , StockInvest.us rates Catalyst Pharmaceuticals (CPRX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Up 24.27%
- 3-month trend forecast Up 1.13%
- High gross margin of 82.3%
- Strong operating margin of 44.8%
- Low bankruptcy risk (Altman Z-Score: 20.00)
Red day on Monday for Catalyst Pharmaceuticals
(Market data through Aug 10, 2026)
No changes to the price of Catalyst Pharmaceuticals stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 0% from a day low at $31.49 to a day high of $31.49. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
The stock is at the lower part of a narrow and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $31.49 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Catalyst Pharmaceuticals stock with a 90% probability to be traded between $31.84 and $32.00 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
CPRX Signals & Forecast
The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.49 and $31.47. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -0.0317%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock
Catalyst Pharmaceuticals finds support from accumulated volume at $31.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%
Our recommended stop-loss: $30.23 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 25 days ago.)
Trading Expectations (CPRX) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Catalyst Pharmaceuticals to open at $31.49, and during the day (based on 14 day Average True Range), to move between $31.49 and $31.49, which gives a possible trading interval of +/-$0.0096 (+/-0.03%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.03% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $31.50 (0.03%) than the support at $31.28 (0.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Catalyst Pharmaceuticals stock A Buy?
Catalyst Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $31.49 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CPRX Performance
Trading levels for CPRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 31.49 | - |
| R2 | 31.49 | - |
| R1 | 31.49 | - |
| Price | 31.49 | |
| S1 | 31.49 | - |
| S2 | 31.49 | - |
| S3 | 31.49 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 31.50 | 0.0318% |
| Price | 31.49 | |
| S1 | 31.28 | -0.667% |
| S2 | 31.23 | -0.83% |
| S3 | 31.16 | -1.05% |
FAQ
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.
Buy CPRX